October 5, 2009 9:29 PM
- Text
Schering's Say-on-Pay Survey Goes M.I.A.
(MoneyWatch) Did Schering-Plough plan -- and then kill or delay -- a "say on pay" survey of its investors? That's one possibility raised by "Condor" at Shearlings Got Plowed, the blog that obsessively examines goings-on at the company that's soon to be merged into Merck.
A say-on-pay survey of Schering investors would be most interesting because CEO Fred Hassan's compensation is famously lavish. BNET previously estimated his payout in the Merck merger at $77 million. Condor thinks it could be $173 million. The WSJ estimates a "mere" $56 million.
Condor's post relies on this blog item by a lawyer named Raphael M. Russo at Paul, Weiss, Rifkind, Wharton & Garrison. The item states:
Adding to the mystery: blogger/lawyer Russo and Schering board member Patricia F. Russo, former CEO of Alcatel-Lucent, share the same last name. Does one Russo know something the rest of us don't?
A say-on-pay survey of Schering investors would be most interesting because CEO Fred Hassan's compensation is famously lavish. BNET previously estimated his payout in the Merck merger at $77 million. Condor thinks it could be $173 million. The WSJ estimates a "mere" $56 million.Condor's post relies on this blog item by a lawyer named Raphael M. Russo at Paul, Weiss, Rifkind, Wharton & Garrison. The item states:
... the company is evaluating a process to complete and discuss the survey before the proposed transaction with Merck closes.No survey was included with the Schering proxy filing, Condor reports. Which raises the question: If the survey was planned but didn't go out to investors with the proxy materials, when, if ever, does Schering want to see that vote published?
Adding to the mystery: blogger/lawyer Russo and Schering board member Patricia F. Russo, former CEO of Alcatel-Lucent, share the same last name. Does one Russo know something the rest of us don't?
- Related:
- Inside Schering's $437M Tax Fraud: "It Doesn't Count If It's in Dutch!"
- Schering's Weird New Nuvaring Ad: "Don't You Have to -- Put It In --?"
- Zyrtec and Claritin's New Eye Drops Contain Neither Zyrtec Nor Claritin
- Leerink Outlines Gloom Potential for Merck/Schering's $2B Zetia Franchise
- Judge Details Schering's "Reprehensible" Off-Label Promotion of Cancer Drugs
- Merck and Schering Q2: Who Needs This Merger More?
- Schering CEO Hassan's Merck Payout Is Millions Greater Than WSJ Thinks It Is
- Does J&J's Move on Remicade Pact Threaten Schering CEO Hassan's $51 Mil. Merger Payout?
- Top Schering Execs Could Get $132 Million in Merck Deal Jackpot
- Schering CEO Hassan Has $59 Million Buyout Agreement in Merck Merger
Latest Now in MoneyWatch
- Jill on Money: Retirement investing, allocation, long term care
- Could "web-lining" be dangerous?
- Insurers respond cautiously to contraceptive plan
- Judge: Legally, breastfeeding not related to pregnancy
- Budget deficit drops to $27 billion in January
- Why the Powerball Jackpot is part of my investment strategy
- Is the new VW Beetle diesel worth the money?
- Consumer sentiment highlights risks to recovery
- Valentine blues? 10 best cities to be single
- December trade deficit widens to $48.8 billion
- Alcatel-Lucent returns to profit in 2011
- 6 things never to say in a performance review
- $26B mortgage deal: Who gets the money?
- Friendly's CEO steps down
- Quarterly loss hits $3.3B at Postal Service
- Greeks rail against cuts as EU demands more
- 6 things you should never share on Facebook
Latest CBS News Headlines
on Facebook
on CBS News
- Marine honored for Afghanistan counterattack
- Marine honored for Afghanistan counterattack
- Pakistan army tries 5 officers over extremist ties
- Pakistan army tries 5 officers over extremist ties
on Facebook
- Adele sings a cappella for Anderson Cooper
- Occupy protestors kicked out of CPAC
- CPAC: Will Sarah Palin spring a surprise?
- Beyonce and Jay-Z post first photos of Blue Ivy Carter
on CBS News






